The study successfully correlated specific compounds with sensory profiles like sweetness and flavor, offering valuable insights to improve predictive models and guide future strawberry breeding ...

Autonomous network operations are transforming telecom Industry, enabling AI-driven visibility, automation and resilience to ...

In this article, we will be taking a look at the 12 Best Robinhood Stocks to Buy Under $10. Officially, Robinhood Markets is ...

Q4 2025 Earnings Call March 19, 2026 5:00 PM EDTCompany ParticipantsYojin Yoon - Vice President of OperationsJoshua ...

A research team has demonstrated how carbon-based diamond–water nanofluids can be strategically engineered to boost heat transfer over complex, wavy ...

ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q4 2025 Earnings Call Transcript March 17, 2026 ClearPoint Neuro, Inc. misses on earnings expectations. Reported EPS is $-0.27498 EPS, expectations were $-0.2.

Denali Therapeutics (NASDAQ:DNLI) founder and CEO Ryan Watts said 2026 is shaping up to be a pivotal year for the company as it approaches a potential first product approval and advances multiple ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AML HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc.

Eco Wave Power Global AB ("Eco Wave Power" or the "Company") (NASDAQ: WAVE), a leading developer of onshore wave energy technology, today announced that its technology was featured in a video ...

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AML HOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc.

Objectives Chronic exertional compartment syndrome (CECS) is traditionally confirmed by intracompartmental pressure (ICP) measurement, but this test has been criticised. The aim of this study was to ...